Both the Sentab project (2015–2017) and PHArA-ON (2019–2024) target older adult users with technology designed to improve quality of life and independent living.
SENTAB ESTONIA OU
Estonian digital health SME building AI-powered platforms and wearable solutions that support independent living for older adults.
Their core work
SENTAB Estonia is a digital health SME specializing in technology solutions for older adults, focusing on social engagement, independent living, and active ageing. Their core product work centers on smart TV-based and wearable platforms that connect seniors with family, caregivers, and services — reducing isolation while generating health-relevant behavioral data. They have experience delivering pilot programs at scale within large EU consortia, integrating AI, cloud computing, and big data analytics into senior-care workflows. Their work sits at the intersection of consumer-facing digital product design and clinical/social care applications.
What they specialise in
PHArA-ON explicitly lists smart wearables as a core keyword, reflecting hands-on integration of sensor hardware with cloud-based health analytics.
PHArA-ON keywords include artificial intelligence, big data, and intelligence analytics platforms, indicating applied data science capability in the ageing context.
Privacy and cybersecurity appear as explicit keywords in PHArA-ON, reflecting compliance and data-protection requirements in health-tech deployments.
PHArA-ON keywords include 'open calls' and 'marketplace', suggesting experience managing third-party developer or service-provider ecosystems within large platform projects.
How they've shifted over time
Their first H2020 project (Sentab, 2015–2017) was a product-led initiative addressing senior loneliness through entertainment technology — likely a smart TV or tablet interface — with SENTAB as coordinator and primary innovator. By the time they joined PHArA-ON (2019–2024), the focus had broadened and technically deepened: the keywords shift entirely toward AI, wearables, big data, cloud infrastructure, and cybersecurity, reflecting a maturation from consumer product to integrated health-data platform. The trajectory suggests the company evolved from building a standalone social app into becoming a technology component supplier for large active-ageing ecosystems.
SENTAB is moving from product creator to platform integrator, positioning itself as a technology provider within large-scale ageing and digital health consortia rather than as a standalone consumer product company.
How they like to work
SENTAB has demonstrated both leadership (coordinating the Sentab project) and partner roles (joining PHArA-ON as a participant), suggesting flexibility depending on the project scope. PHArA-ON is a large IA-type consortium with 58 unique partners across 13 countries, meaning SENTAB has experience operating inside complex multi-stakeholder environments. As a small SME, they likely contribute a focused technology component or pilot site rather than driving overall project governance in larger consortia.
SENTAB has built connections with 58 unique partners across 13 countries, primarily through PHArA-ON — a geographically diverse active-ageing consortium spanning multiple European regions. Their network is broad for a 2-project SME, though it reflects the scale of the PHArA-ON consortium rather than a long personal partnership history.
What sets them apart
SENTAB is one of very few Estonian SMEs with both a coordination track record and participation in a major active-ageing innovation action, giving them credibility rare for a company of their size. Their dual experience — building a consumer-facing senior product from scratch AND integrating into a 58-partner EU platform project — means they understand both product delivery and consortium dynamics. For a consortium looking for a focused digital-health technology contributor from the Baltic region with real pilot experience, SENTAB fills a specific and hard-to-find niche.
Highlights from their portfolio
- SentabSENTAB coordinated this SME Instrument Phase 2 project worth EUR 1.638M — the highest-funded project in their portfolio and evidence of their ability to lead and deliver a commercial-stage digital product independently.
- PHArA-ONA large Innovation Action running 2019–2024 with broad European reach, this project signals SENTAB's integration into the mainstream active-ageing research ecosystem and their credibility as a component technology provider in complex consortia.